Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q2T3N9

Entry ID Method Resolution Chain Position Source
AF-Q2T3N9-F1 Predicted AlphaFoldDB

No variants for Q2T3N9

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q2T3N9

No associated diseases with Q2T3N9

4 regional properties for Q2T3N9

Type Name Position InterPro Accession
domain AMP-dependent synthetase/ligase domain 89 - 526 IPR000873
conserved_site AMP-binding, conserved site 263 - 274 IPR020845
domain AMP-binding enzyme, C-terminal domain 535 - 613 IPR025110
domain Acetyl-coenzyme A synthetase, N-terminal domain 24 - 79 IPR032387

Functions

Description
EC Number 6.2.1.1 Acid--thiol ligases
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

4 GO annotations of molecular function

Name Definition
acetate-CoA ligase activity Catalysis of the reaction: ATP + acetate + CoA = AMP + diphosphate + acetyl-CoA.
AMP binding Binding to AMP, adenosine monophosphate.
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
metal ion binding Binding to a metal ion.

1 GO annotations of biological process

Name Definition
acetyl-CoA biosynthetic process from acetate The chemical reactions and pathways resulting in the formation of acetyl-CoA from acetate, either directly or via acetylphosphate.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MSAIESVLHE RRQFAPPAAV EKAAAISGMA AYRALAEEAE RDYEGFWARL ARETLEWRKP
70 80 90 100 110 120
FGKALDETNA PFYKWFDDGE LNASYNCLDR HVAAGLGERI AVIFEADDGT VARVTYADLL
130 140 150 160 170 180
ARVSRFANAL KKRGIGRGDR VVIYIPMSVE GIVAMQACAR IGATHSVVFG GFSSKSLHER
190 200 210 220 230 240
IVDVGATALV TADEQMRGGK TLPLKSIADE ALAMGGCDAV KTVVVYRRTG GNVDWHAGRD
250 260 270 280 290 300
VWMHEIVANE SDACEPEWVG AEHPLFILYT SGSTGKPKGV QHSTAGYLLW VAQTMKWTFD
310 320 330 340 350 360
WKPDDVFWCT ADIGWVTGHS YITYGPLAVG ATQVVFEGVP TYPNAGRFWK MIGDHKVSVF
370 380 390 400 410 420
YTAPTAIRSL IKAAEADEHV HPKSYDLSSL RIIGTVGEPI NPEAWIWYHK NVGQERCPIV
430 440 450 460 470 480
DTWWQTETGG HMITPLPGAT PTVPGSCTLP LPGIMAAVVD ETGQDVPNGQ GGILVVKRPW
490 500 510 520 530 540
PAMARTIWGD PERFKKSYFP DELGGRLYLA GDGTVRDKET GYFTIMGRID DVLNVSGHRL
550 560 570 580 590 600
GTMEIESALV SHELVAEAAV VGRPDDTTGE AVVAFVVLKR SRPEGEEAAA LAKTLRDWVG
610 620 630 640 650
KEIGPIAKPK DIRFGDNLPK TRSGKIMRRL LRSLAKGEAI TQDTSTLENP AILEQLAEVR